Search

Displaying results 8891 - 8900 of 10000 in total
  1. Drug

    Distigmine

    go.drugbank.com/drugs/DB13694
    Investigational

    Distigmine is a parasympathomimetic agent with a longer duration of action and enhanced drug accumulation compared to [DB00545] and [DB01400]. … Distigmine is available in several countries as a treatment of underactive detrusor and voiding dysfunction in the urinary tract where the active ingredient is distigmine bromide.

    Categories: Heterocyclic Compounds, 1-RingProducts: UBRETID TABLET 5 mg, Ubretid 5 mg - Tabletten
  2. Drug

    Diphemanil

    go.drugbank.com/drugs/DB13720
    ApprovedVet approvedWithdrawn

    Categories: Heterocyclic Compounds, 1-Ring
  3. Drug

    Iocarmic acid

    go.drugbank.com/drugs/DB13755
    Experimental

    Categories: X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting
  4. Drug

    Fenpiverinium

    go.drugbank.com/drugs/DB13759
    Investigational

    Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Rufloxacin

    go.drugbank.com/drugs/DB13772
    Investigational

    Rufloxacin is a quinolone antibiotic.[A31894]

    Categories: 4-Quinolones, Heterocyclic Compounds, 2-Ring
  6. Drug

    Tilidine

    go.drugbank.com/drugs/DB13787
    Investigational

    Mixtures: VALORON N, VALORON NCategories: P-glycoprotein inhibitors, Cytochrome P-450 Substrates
  7. Drug

    Timepidium

    go.drugbank.com/drugs/DB13850
    Investigational

    Synonyms: 3-(di-2-thienylmethylene)-5-methoxy-1,1-dimethyl-piperidiniumCategories: Heterocyclic Compounds, 1-Ring
  8. Drug

    Dimazole

    go.drugbank.com/drugs/DB13858
    ApprovedWithdrawn

    Dimazole (diamthazole) is an antifungal. It was withdrawn in Franch in 1972 due to neuropsychiatric reactions.

    Categories: Heterocyclic Compounds, 1-Ring
  9. Drug

    Enasidenib

    go.drugbank.com/drugs/DB13874
    ApprovedInvestigational

    gene, which is a recurrent mutation detected in 12-20% of adult patients with AML [A20344, A20345]. … Food and Drug Administration on August 1, 2017.

    Categories: Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates with a Narrow Therapeutic IndexSynonyms: 2-Methyl-1-(4-(6-(trifluoromethyl)pyridin-2-yl)-6-(2-(trifluoromethyl)pyridin-4-ylamino)-1,3,5-triazin-2-ylamino)propan-2-ol
  10. Drug

    Harmaline

    go.drugbank.com/drugs/DB13875
    Experimental

    Categories: Heterocyclic Compounds, 2-Ring, Heterocyclic Compounds, 3-Ring